Skip to main content
. 2017 Jun 26;30(5):542–549. doi: 10.20524/aog.2017.0170

Table 4.

Patients with contraindications due to drug-drug interactions (DDIs) or potential DDIs to hepatitis C virus (HCV) direct-acting antivirals among 174 (35%) of 500 HCV patients who were on co-medications

graphic file with name AnnGastroenterol-30-542-g005.jpg